menu
    • menu

    Company profile for Orbis Medicines

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Orbis Medicines stands at the forefront of oral macrocycle drug discovery. Our extensive pipeline is primarily directed towards developing oral macrocycle candidates targeting validated targets akin to blockbuster biologic drugs. Our objective is to introduce oral alternatives that offer significant benefits to healthcare, extending treatment options to a larger patient population. Furthermore, we are actively investigating a ...
    Orbis Medicines stands at the forefront of oral macrocycle drug discovery. Our extensive pipeline is primarily directed towards developing oral macrocycle candidates targeting validated targets akin to blockbuster biologic drugs. Our objective is to introduce oral alternatives that offer significant benefits to healthcare, extending treatment options to a larger patient population. Furthermore, we are actively investigating a diverse range of therapeutic areas encompassing appealing target classes, including both intra- and extracellular targets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Orbis MedicinesDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Nordre Fasanvej 215, DK-2000 Frederiksberg, Denmark
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.orbismedicines.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/orbismedicines/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Orbis Boosts Oral Macrocycle Platform With Gefion AI
    Orbis Boosts Oral Macrocycle Platform With Gefion AI

    03 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250602008140/en/Orbis-Medicines-Accelerates-Next-Generation-Oral-Macrocycle-Platform-with-Enhanced-Artificial-Intelligence-Capabilities-of-Gefion-Supercomputer

    BUSINESSWIRE
    03 Jun 2025
    Share Share
    Orbis Medicines Names Veteran R&D Leader Mikael Dolsten Board Chair
    Orbis Medicines Names Veteran R&D Leader Mikael Dolsten Board Chair

    05 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250304557995/en

    BUSINESSWIRE
    05 Mar 2025
    Share Share
    Orbis Medicines Secures Funding For Oral Macrocycles Pipeline
    Orbis Medicines Secures Funding For Oral Macrocycles Pipeline

    07 Jan 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/orbis-medicines-gets-funding-to-develop-pipeline-of-oral-macrocycles/

    CONTRACTPHARMA
    07 Jan 2025
    Share Share
    Orbis Medicines to Expand With New R&D Site in Copenhagen
    Orbis Medicines to Expand With New R&D Site in Copenhagen

    03 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241003861940/en

    BUSINESSWIRE
    03 Oct 2024
    Share Share
    Orbis And Vivtex Collaborate To Develop Orally Dosable Next-Gen nCycles
    Orbis And Vivtex Collaborate To Develop Orally Dosable Next-Gen nCycles

    17 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240917637940/en

    BUSINESSWIRE
    17 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search